ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway

BACKGROUND: Excision Repair Cross-Complementation group 6-like (ERCC6L) has been shown to exhibit carcinogenic effect in several malignant tumors. However, the function and molecular mechanism of the ERCC6L in hepatocellular carcinoma (HCC) have not been investigated extensively. METHODS: Immunohist...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Han, Wang, Hengxiao, Yu, Xiqiao, Zhou, Shuping, Zhang, Yueying, Wang, Zhaopeng, Huang, Shuhong, Wang, Zhaoxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487553/
https://www.ncbi.nlm.nih.gov/pubmed/32891122
http://dx.doi.org/10.1186/s12885-020-07367-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487553/
https://www.ncbi.nlm.nih.gov/pubmed/32891122
http://dx.doi.org/10.1186/s12885-020-07367-2

Ejemplares similares